4//SEC Filing
Leyman Barbara 4
Accession 0001415889-25-010383
CIK 0001382101other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:09 PM ET
Size
8.1 KB
Accession
0001415889-25-010383
Insider Transaction Report
Form 4
Leyman Barbara
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-04+91,000→ 91,000 totalExercise: $0.55Exp: 2035-04-04→ Common Stock (91,000 underlying) - Award
Restricted Stock Units (RSUs)
2025-04-04+84,500→ 84,500 totalExp: 2029-03-02→ Common Stock (84,500 underlying)
Footnotes (3)
- [F1]The option vests as to 2.0833% of the total award monthly, beginning on May 4, 2025, with 100% of the award being vested and exercisable on April 4, 2029, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 2, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0002028309
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:09 PM ET
- Size
- 8.1 KB